In tamoxifen-resistant cancers, the ER coactivator HOXB7 exhibits an increased expression and may activate kinase phosphorylation of both EGFR [189] and HER2 [190], promoting unliganded ER activation. The gene discussed is ESR1; the disease is cancer.